376 related articles for article (PubMed ID: 38149674)
1. Clinical considerations on monkeypox antiviral medications: An overview.
Pourkarim F; Entezari-Maleki T
Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
[TBL] [Abstract][Full Text] [Related]
3. Emerging pharmacological strategies for treating and preventing mpox.
Grosenbach DW; Russo AT; Blum ED; Hruby DE
Expert Rev Clin Pharmacol; 2023; 16(9):843-854. PubMed ID: 37592723
[TBL] [Abstract][Full Text] [Related]
4. Drug Interactions Between Psychotropic Medications and Treatment of Mpox (tecovirimat and cidofovir).
Mansuri Z; Shah B; Yadav G; Kainth T; Kochhar H; Srinivas S; Kamil SH; Bachu A; Reddy A
Prim Care Companion CNS Disord; 2024 Feb; 26(1):. PubMed ID: 38382079
[No Abstract] [Full Text] [Related]
5. Treatment and Vaccination for Smallpox and Monkeypox.
Saalbach KP
Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586
[TBL] [Abstract][Full Text] [Related]
6. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic targets for Mpox: the evidence to date.
Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K
Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans.
Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S
Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888
[TBL] [Abstract][Full Text] [Related]
9. Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations.
Frenois-Veyrat G; Gallardo F; Gorgé O; Marcheteau E; Ferraris O; Baidaliuk A; Favier AL; Enfroy C; Holy X; Lourenco J; Khoury R; Nolent F; Grosenbach DW; Hruby DE; Ferrier A; Iseni F; Simon-Loriere E; Tournier JN
Nat Microbiol; 2022 Dec; 7(12):1951-1955. PubMed ID: 36344621
[TBL] [Abstract][Full Text] [Related]
10. Potential use of cidofovir, brincidofovir, and tecovirimat drugs in fighting monkeypox infection: recent trends and advancements.
Rani I; Joshi H; Sharma U; Kaur J; Sood S; Ramniwas S; Chauhan A; Abdulabbas HS; Tuli HS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2055-2065. PubMed ID: 37837475
[TBL] [Abstract][Full Text] [Related]
11. Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models.
Cinatl J; Bechtel M; Reus P; Ott M; Rothweiler F; Michaelis M; Ciesek S; Bojkova D
J Med Virol; 2024 Jan; 96(1):e29354. PubMed ID: 38180134
[TBL] [Abstract][Full Text] [Related]
12. Managing Monkeypox Virus Infections: A Contemporary Review.
Asadi Noghabi F; G Rizk J; Makkar D; Roozbeh N; Ghelichpour S; Zarei A
Iran J Med Sci; 2024 Jan; 49(1):1-9. PubMed ID: 38322157
[TBL] [Abstract][Full Text] [Related]
13. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis.
Shamim MA; Satapathy P; Padhi BK; Veeramachaneni SD; Akhtar N; Pradhan A; Agrawal A; Dwivedi P; Mohanty A; Pradhan KB; Kabir R; Rabaan AA; Alotaibi J; Al Ismail ZA; Alsoliabi ZA; Al Fraij A; Sah R; Rodriguez-Morales AJ
Front Pharmacol; 2023; 14():1149909. PubMed ID: 37214444
[TBL] [Abstract][Full Text] [Related]
15. Lack of clinical evidence of antiviral therapy for human monkeypox: A scoping review.
Kuroda N; Shimizu T; Hirano D; Ishikane M; Kataoka Y
J Infect Chemother; 2023 Feb; 29(2):228-231. PubMed ID: 36283609
[TBL] [Abstract][Full Text] [Related]
16. Antivirals With Activity Against Mpox: A Clinically Oriented Review.
Siegrist EA; Sassine J
Clin Infect Dis; 2023 Jan; 76(1):155-164. PubMed ID: 35904001
[TBL] [Abstract][Full Text] [Related]
17. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?
Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA
Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577
[TBL] [Abstract][Full Text] [Related]
18. Update on monkeypox virus infection: Focusing current treatment and prevention approaches.
Dhapola R; Kumari S; Sharma P; KumarKushawaha P; HariKrishnaReddy D
Fundam Clin Pharmacol; 2024 Jun; 38(3):465-478. PubMed ID: 38226405
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
De Clercq E; Jiang Y; Li G
Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
[TBL] [Abstract][Full Text] [Related]
20. Monkeypox treatment: Current evidence and future perspectives.
Khani E; Afsharirad B; Entezari-Maleki T
J Med Virol; 2023 Jan; 95(1):e28229. PubMed ID: 36253931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
